We suggest here that overexpression of wild-type RRAS2, and not activating mutations in RAS members, is what drives transformation of mature B cells towards CLL, at least in 82% of these leukemias. The gene discussed is RRAS2; the disease is B-cell chronic lymphocytic leukemia.